V540D

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V540D, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) [Phase 1]